ICF Secures $300 Million in New European Contracts

European Institutions Select Company to Provide Services Across All 27 EU Member States ICF (NASDAQ: ICFI), a leading global solutions and technology provider, has secured two significant new contracts with European institutions to design and deliver large-scale public communication campaigns across all 27 European Union (EU) Member States. The contracts, one single-award and one multiple-award, […]

Rocky Mountain Chocolate Factory Reports Third Quarter Fiscal 2026 Financial Results

(NASDAQ:RMCF), Improved Operating Performance Drives Meaningful Gains in Gross Margin and Profitability Executed Milestone Franchise Area Development Agreement to Bring 34 New Stores to Market Management to Host Conference Call Wednesday at 9:00 a.m. Eastern Time DURANGO, Colo., Jan. 13, 2026 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory, Inc. (Nasdaq: RMCF) (the “Company”, “we”, “RMCF”,

Runway Growth Finance Corp. Provides Fourth Quarter 2025 Portfolio and Transaction Update

(NASDAQ:RWAY), Completed Seven Investments in New and Existing Portfolio Companies Representing $42.9 Million in Funded Investments MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today

Concrete Pumping Holdings Reports Fourth Quarter and Fiscal Year 2025 Results

(NASDAQ:BBCP),(Pinksheets:BBCPW),(PinkSheets:BBCPW), DENVER, Jan. 13, 2026 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider of concrete pumping and waste management services in the U.S. and U.K., reported financial results for the fourth quarter and full year ended October 31, 2025. Fourth Quarter Fiscal Year 2025 Summary vs. Fourth

Hanmi Financial Corporation Announces Fourth Quarter 2025 Earnings and Conference Call Date

(NASDAQ:HAFC), LOS ANGELES, Jan. 13, 2026 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report fourth quarter 2025 financial results after the market close on Tuesday, January 27, 2026. Management will host a conference call that same day, at 2:00 p.m. Pacific Time

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium

(NasdaqGM:FHTX), WATERTOWN, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) — Foghorn(R) Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced the closing of its $50 million registered direct financing at a 30% premium. The registered direct offering included the sale

Grocery Outlet Holding Corp. Announces Chief Purchasing Officer Retirement

(NASDAQ:GO), EMERYVILLE, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet” or the “Company”) today announced that Steve Wilson, EVP and Chief Purchasing Officer, will retire effective March 20, 2026, after 31 years of service. Industry veteran Matt Delly, who joined Grocery Outlet last year as Chief Merchandising Officer,

America’s Car-Mart Advances SG&A Cost Control Strategy With Phase 2 Store Consolidations

(NASDAQ:CRMT), ROGERS, Ark., Jan. 13, 2026 (GLOBE NEWSWIRE) — America's Car-Mart, Inc. (NASDAQ: CRMT) (“Car-Mart” or the “Company”) today announced the completion of Phase 2 of its previously announced SG&A Cost Control Strategy through footprint optimization, which includes the consolidation of 13 locations into higher-performing nearby dealerships. This realignment follows five store consolidations that were

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

(NasdaqGM:BBOT), SOUTH SAN FRANCISCO, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced it awarded an inducement grant on January 10, 2026 under BBOT's 2025 Inducement Plan as a material inducement to the employment of an individual hired by

Scroll to Top